Stroke drug trial halted after just two patients
NCT ID NCT06107725
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aimed to see if the antibiotic minocycline could improve outcomes after a stroke. Participants were to receive either standard care plus minocycline pills for five days, or standard care alone. However, the trial was stopped early after enrolling only 2 people, so no meaningful results were obtained.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Minocycline (an antibiotic) taken as 200 mg pills once daily for five days
- What this could lead to
- If it worked, minocycline might offer a simple, cheap way to improve recovery and reduce death after a stroke.
- What could go wrong
- The trial was terminated after enrolling only 2 people, so no reliable conclusions can be drawn. Minocycline's benefit for stroke remains unproven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMORRHAGIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Maimonides Medical Center
Brooklyn, New York, 11219, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Zapping the brain to restore swallowing after stroke?
- Can Brain-Triggered stimulation reawaken arms after stroke?
- Could a stent double the chance of a good recovery after severe stroke?
- Could starting feeds sooner shield preterm babies from infection?
- Can lifestyle choices after a stroke extend life and prevent a second one?
- Can a gentle ear zap supercharge stroke rehab at home?